ESPAC-4: A Multicenter, International, Randomized Controlled Phase III Trial of Adjuvant Combination Chemotherapy of Gemcitabine (GEM) and Capecitabine (CAP), Versus Monotherapy Gemcitabine in Patients With Resected Pancreatic Ductal Adenocarcinoma

被引：0
|
作者：
Neoptolemos, J. P. [1 ]
Palmer, D. [1 ]
Ghaneh, P. [1 ]
Valle, J. [2 ,3 ]
Cunningham, D. [4 ]
Wadsley, J. [5 ]
Meyer, T. [6 ]
Anthoney, A. [7 ]
Glimelius, B. [8 ]
Falk, S. [9 ]
Lind, P. [10 ]
Izbicki, J. [11 ]
Middleton, G. [12 ]
Ross, P. [13 ]
Wasan, H. [14 ]
McDonald, A. [15 ]
Crosby, T. [16 ]
Psarelli, E. [1 ]
Hammel, P. [17 ]
Buechler, M. W. [18 ]
机构：
[1] Univ Liverpool, Liverpool, Merseyside, England
[2] Univ Manchester, Manchester, Lancs, England
[3] Christie, Manchester, Lancs, England
[4] Royal Marsden Hosp, London, England
[5] Weston Pk Hosp, Sheffield, S Yorkshire, England
[6] Royal Free Hosp, London, England
[7] St James Univ Hosp, Leeds, W Yorkshire, England
[8] Uppsala Univ, Uppsala, Sweden
[9] Bristol Haematol & Oncol Ctr, Bristol, Avon, England
[10] Karolinska Univ Hosp, Stockholm, Sweden
[11] Univ Hamburg, Med Inst UKE, Hamburg, Germany
[12] Royal Surrey Cty Hosp, Guildford, Surrey, England
[13] Guys Hosp, London, England
[14] Hammersmith Hosp, London, England
[15] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[16] Velindre Hosp, Cardiff, S Glam, Wales
[17] Hop Beaujon, Clichy, France
[18] Heidelberg Univ, Heidelberg, Germany
来源：
PANCREAS | 2016年 / 45卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1529 / 1529
页数：1
相关论文
共 50 条
  • [31] A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy-naive Pancreatic Adenocarcinoma
    Cohen, Steven J.
    Zalupski, Mark M.
    Conkling, Paul
    Nugent, Francis
    Ma, Wen Wee
    Modiano, Manuel
    Pascual, Rolan
    Lee, Fa Chyi
    Wong, Lucas
    Hersh, Evan
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (03): : 230 - 235
  • [32] APACT: A Phase III Trial of Nab-Paclitaxel (nab-P) Plus Gemcitabine (Gem) Versus Gem Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (PC)
    Tempero, Margaret
    Cardin, Dana
    Biankin, Andrew
    Goldstein, David
    Moore, Malcolm
    O'Reilly, Eileen
    Philip, Philip
    Riess, Hanno
    Macarulla, Teresa
    Yung, Lotus
    Wei, Xinyu
    Lu, Brian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S72 - S72
  • [33] Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater
    Neoptolemos, J. P.
    Moore, M. J.
    Cox, T. F.
    Valle, J. W.
    Palmer, D. H.
    Mcdonald, A.
    Carter, R.
    Tebbutt, N. C.
    Dervenis, C.
    Smith, D.
    Glimelius, B.
    Coxon, F. Y.
    Lacaine, F.
    Middleton, M. R.
    Ghaneh, P.
    Bassi, C.
    Halloran, C.
    Olah, A.
    Rawcliffe, C. L.
    Buechler, M. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18)
  • [34] Phase III APACT trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P plus Gem) versus gemcitabine (Gem) alone for patients with resected pancreatic cancer (PC): Outcomes by geographic region.
    Reni, Michele
    Riess, Hanno
    O'Reilly, Eileen Mary
    Park, Joon Oh
    Hatoum, Hassan
    Saez, Berta Laquente
    Salminen, Tapio
    Oettle, Helmut
    Lopez, Rafael
    Dowden, Scot D.
    Karthaus, Meinolf
    Tabernero, Josep
    Van Cutsem, Eric
    Philip, Philip Agop
    Goldstein, David
    Berlin, Jordan
    Tempero, Margaret A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [35] Randomized multicenter phase II/III study with adjuvant gemcitabine versus neoadjuvant/adjuvant FOLFIRINOX in resectable pancreatic cancer: The NEPAFOX trial.
    Hozaeel, Wael
    Pauligk, Claudia
    Homann, Nils
    Luley, Kim
    Kraus, Thomas Werner
    Trojan, Jorg
    Bechstein, Wolf O.
    Grimm, Kersten
    Heise, Bettina
    Schmiegel, Wolff
    Pink, Daniel
    Al-Batran, Salah-Eddin
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [36] Randomized multicenter phase II/III study with adjuvant gemcitabine versus neoadjuvant/adjuvant FOLFIRINOX in resectable pancreatic cancer: The NEPAFOX trial.
    Al-Batran, Salah-Eddin
    Reichart, Alexander
    Bankstahl, Ulli Simone
    Pauligk, Claudia
    Kraus, Thomas Werner
    Bechstein, Wolf Otto
    Trojan, Jorg
    Behrend, Matthias
    Potenberg, Jochem
    Homann, Nils
    Venerito, Marino
    Bohle, Wolfram
    Varvenne, Michael
    Bolling, Claus
    Behringer, Dirk M.
    Kratz-Alber, Karsten
    Siegler, Gabriele Margareta
    Hozaeel, Wael
    Goetze, Thorsten Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [37] Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater
    Neoptolemos, J. P.
    Moore, M. J.
    Cox, T. F.
    Valle, J. W.
    Palmer, D. H.
    Mcdonald, A.
    Carter, R.
    Tebbutt, N. C.
    Dervenis, C.
    Smith, D.
    Glimelius, B.
    Coxon, F. Y.
    Lacaine, F.
    Middleton, M. R.
    Ghaneh, P.
    Bassi, C.
    Halloran, C.
    Olah, A.
    Rawcliffe, C. L.
    Buechler, M. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [38] KG 4/2015: A randomized, controlled, multicenter, open-label phase III clinical trial of GV1001 with gemcitabine/capecitabine in previous untreated, eotaxin-high patients with advanced pancreatic ductal adenocarcinoma.
    Jo, Jung Hyun
    Kim, Yong-Tae
    Choi, Ho Soon
    Kim, Ho Gak
    Lee, Hong Sik
    Choi, Young Woo
    Kim, Dong Uk
    Lee, Kwang Hyuck
    Kim, Eui Joo
    Han, Jeong Ho
    Lee, Seung Ok
    Park, Chang-Hwan
    Choi, Eun Kwang
    Lee, Kyong Joo
    Cho, Jae Yong
    Lee, Woo Jin
    Song, Si Young
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [39] Phase III, international, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P plus G) versus gemcitabine (G) for resected pancreatic cancer (APACT): Recurrence patterns
    Sahai, Vaibhav
    Tabernero, Josep
    Van Cutsem, Eric
    Reni, Michele
    Tempero, Margaret A.
    O'Reilly, Eileen Mary
    Berlin, Jordan
    Riess, Hanno
    Goldstein, David
    Li, Mingyu
    Lu, Brian
    Ferrara, Stefano
    Philip, Philip Agop
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [40] Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma The ESPAC-3 Periampullary Cancer Randomized Trial
    Neoptolemos, John P.
    Moore, Malcolm J.
    Cox, Trevor F.
    Valle, Juan W.
    Palmer, Daniel H.
    McDonald, Alexander C.
    Carter, Ross
    Tebbutt, Niall C.
    Dervenis, Christos
    Smith, David
    Glimelius, Bengt
    Charnley, Richard M.
    Lacaine, Francois
    Scarfe, Andrew G.
    Middleton, Mark R.
    Anthoney, Alan
    Ghaneh, Paula
    Halloran, Christopher M.
    Lerch, Markus M.
    Olah, Attila
    Rawcliffe, Charlotte L.
    Verbeke, Caroline S.
    Campbell, Fiona
    Buechler, Markus W.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (02): : 147 - 156
12345